ORBi: Vander Cruyssen B. - The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues of the optimization of rituximab treatment strategies.

Reference : The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues of the optimization ...


	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Rheumatology
	To cite this reference:	http://hdl.handle.net/2268/110884

Title :	The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues of the optimization of rituximab treatment strategies.
Language :	English
Author, co-author :	Vander Cruyssen, B. [ > > ]
	Durez, P. [ > > ]
	Westhovens, R. [ > > ]
	KAISER, Marie-Joëlle [Centre Hospitalier Universitaire de Liège - CHU > > Rhumatologie >]
	Hoffman, I. [ > > ]
	De Keyser, F. [ > > ]
	MIRA Study Group [ > > ]
Other contributor :	Malaise, Michel [Université de Liège - ULg > Département des sciences cliniques > Rhumatologie >]
Publication date :	10-Sep-2010
Journal title :	Arthritis Research & Therapy
Publisher :	BioMed Central
Volume :	12
Issue/season :	5
Special issue title :	Arthritis Res Ther.
Pages :	169
Audience :	International
ISSN :	1478-6354
e-ISSN :	1478-6362
City :	London
Country :	United Kingdom
Keywords :	[en] The Belgian MIRA registry
Permalink :	http://hdl.handle.net/2268/110884

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	Vander Cruyssen_Arthritis Research Therapy_2010_12_R169.pdf		Publisher postprint	520.56 kB	Request copy

All documents in ORBi are protected by a user license.